Tag: Orphan Drugs 2020 FDA Approvals: A Year in Review by Magellan Health Insights March 15, 2021 CDER, Center for Drug Evaluation and Research, FDA, FDA Approvals, Food and Drug Administration, Magellan Health, New Drugs, Novel drugs, Orphan Drugs 2019 FDA Approvals: A Year in Review by Magellan Health Insights March 19, 2020 Biosimilairs, FDA, FDA Approvals, Magellan Health, New Drugs, Novel drugs, Orphan Drugs, Trend Alert Trend Alert: FDA Approvals – A Year in Review by Magellan Health Insights March 22, 2019 Biosimilars, FDA, FDA Approvals, Magellan, Magellan Health, Magellan Healthcare, New Drug Therapy Approvals, Novel drugs, Orphan Drugs, Rare Diseases